Search Results - Kent A. Robertson
- Showing 1 - 10 results of 10
-
1
-
2
-
3
-
4
Semiquantitative Epstein-Barr Virus (EBV) Polymerase Chain Reaction for the Determination of Patients at Risk for EBV-Induced Lymphoproliferative Disease After Stem Cell Transplant... by Kenneth G. Lucas, Robert L. Burton, Sarah E. Zimmerman, Jinghong Wang, Kenneth Cornetta, Kent A. Robertson, Chao H. Lee, David J. Emanuel
Published 1998Artigo -
5
The embryonic stem cell transcription factors Oct-4 and FoxD3 interact to regulate endodermal-specific promoter expression by Ying Guo, Robert H. Costa, H. E. Ramsey, Trevor Starnes, Gail H. Vance, Kent A. Robertson, Mark R. Kelley, Rolland Reinbold, Hans R. Schöler, Robert Hromas
Published 2002Artigo -
6
Biomarkers for Diagnosis and Prognosis of Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation by Ayman Akil, Qing Zhang, Christen L. Mumaw, Nisha Raiker, Jeffrey Yu, Nieves Vélez de Mendizábal, Laura S. Haneline, Kent A. Robertson, Jodi Skiles, Maribel Díaz‐Ricart, Enric Carreras, Jamie L. Renbarger, Samir Hanash, Robert R. Bies, Sophie Paczesny
Published 2015Artigo -
7
Nf1-Dependent Tumors Require a Microenvironment Containing Nf1+/−- and c-kit-Dependent Bone Marrow by Feng‐Chun Yang, David A. Ingram, Shi Chen, Yuan Zhu, Jin Yuan, Xiaohong Li, Xianlin Yang, Scott M. Knowles, Whitney Horn, Yan Li, Shaobo Zhang, Yanzhu Yang, Saeed T. Vakili, Menggang Yu, Dennis K. Burns, Kent A. Robertson, Gary D. Hutchins, Luis F. Parada, D. Wade Clapp
Published 2008Artigo -
8
Recommendations for imaging tumor response in neurofibromatosis clinical trials by Eva Dombi, Simone Ardern‐Holmes, Dusica Babovic‐Vuksanovic, Fred G. Barker, Steve Connor, D. Gareth Evans, Michael J. Fisher, Stéphane Goutagny, Gordon J. Harris, Diego Jaramillo, Matthias A. Karajannis, Bruce R. Korf, Victor Mautner, Scott R. Plotkin, Tina Young Poussaint, Kent A. Robertson, Chie‐Schin Shih, Brigitte C. Widemann
Published 2013Artigo -
9
Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial by Kent A. Robertson, Grzegorz Nalepa, Feng‐Chun Yang, Daniel C. Bowers, Chang Yueh Ho, Gary D. Hutchins, James M. Croop, Terry A. Vik, Scott C. Denne, Luis F. Parada, Cynthia M. Hingtgen, Laurence E. Walsh, Menggang Yu, Kamnesh R. Pradhan, Mary Edwards‐Brown, Mervyn D. Cohen, James Fletcher, Jeffrey B. Travers, Karl Staser, Melissa W. Lee, Marcie R. Sherman, Cynthia J. Davis, Lucy Miller, David A. Ingram, D. Wade Clapp
Published 2012Artigo -
10
Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial by Michael J. Fisher, Chie‐Schin Shih, Steven D. Rhodes, Amy E. Armstrong, Pamela L. Wolters, Eva Dombi, Chi Zhang, Steven P. Angus, Gary L. Johnson, Roger J. Packer, Jeffrey C. Allen, Nicole J. Ullrich, Stewart Goldman, David H. Gutmann, Scott R. Plotkin, Tena Rosser, Kent A. Robertson, Brigitte C. Widemann, Abbi E. Smith, Waylan Bessler, Yongzheng He, Su Jeong Park, Julie A. Mund, Jiang Li, Khadijeh Bijangi‐Vishehsaraei, Coretta Thomas Robinson, Gary Cutter, Bruce R. Korf, Chie‐Schin Shih, Amy E. Armstrong, Jaishri O. Blakeley, D. Wade Clapp
Published 2021Artigo
Search Tools:
Related Subjects
Biology
Gene
Medicine
Biochemistry
Cell biology
Genetics
Immunology
Internal medicine
Neurofibromatosis
Cancer research
Gastroenterology
Molecular biology
Pathology
Receptor
Retinoic acid
Retinoic acid receptor
Retinoic acid-inducible orphan G protein-coupled receptor
Transcription factor
Adverse effect
Cancer
Cell culture
Cellular differentiation
Chemistry
Embryonic stem cell
Haematopoiesis
Myeloid leukemia
Neurofibroma
Nuclear receptor
Oncology
Organic chemistry